SPARC Promotes Cathepsin B-Mediated Melanoma Invasiveness through a Collagen I/α2β1 Integrin Axis
In melanoma, the extracellular protein SPARC (secreted protein acidic and rich in cysteine) is related to tumor progression. Some of the evidence that links SPARC to melanoma progression indicates that SPARC may be involved in the acquisition of mesenchymal traits that favor metastatic dissemination...
Saved in:
Published in | Journal of investigative dermatology Vol. 131; no. 12; pp. 2438 - 2447 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York, NY
Elsevier Inc
01.12.2011
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | In melanoma, the extracellular protein SPARC (secreted protein acidic and rich in cysteine) is related to tumor progression. Some of the evidence that links SPARC to melanoma progression indicates that SPARC may be involved in the acquisition of mesenchymal traits that favor metastatic dissemination. However, no molecular pathways that link extracellular SPARC to a mesenchymal phenotype have been described. In this study, global protein expression analysis of the melanoma secretome following enforced downregulation of SPARC expression led us to elucidate a new molecular mechanism by which SPARC promotes cathepsin B-mediated melanoma invasiveness using collagen I and α2β1 integrins as mediators. Interestingly, we also found that the transforming growth factor (TGF)-β1 contribution to cathepsin B-mediated invasion is highly SPARC dependent. In addition, induction of the E-cadherin to N-cadherin switch by SPARC enabled melanoma cells to transmigrate across an endothelial layer through a mechanism independent to that of enhancing invasion. Finally, SPARC also enhanced the extracellular expression of other proteins involved in epithelial–mesenchymal transformation, such as family with sequence similarity 3, member C/interleukin-like EMT-inducer. Our findings demonstrate a previously unreported molecular pathway for SPARC activity on invasion and support an active role of SPARC in the mesenchymal transformation that contributes to melanoma dissemination. |
---|---|
AbstractList | In melanoma, the extracellular protein SPARC (secreted protein acidic and rich in cysteine) is related to tumor progression. Some of the evidence that links SPARC to melanoma progression indicates that SPARC may be involved in the acquisition of mesenchymal traits that favor metastatic dissemination. However, no molecular pathways that link extracellular SPARC to a mesenchymal phenotype have been described. In this study, global protein expression analysis of the melanoma secretome following enforced downregulation of SPARC expression led us to elucidate a new molecular mechanism by which SPARC promotes cathepsin B-mediated melanoma invasiveness using collagen I and α2β1 integrins as mediators. Interestingly, we also found that the transforming growth factor (TGF)-β1 contribution to cathepsin B-mediated invasion is highly SPARC dependent. In addition, induction of the E-cadherin to N-cadherin switch by SPARC enabled melanoma cells to transmigrate across an endothelial layer through a mechanism independent to that of enhancing invasion. Finally, SPARC also enhanced the extracellular expression of other proteins involved in epithelial–mesenchymal transformation, such as family with sequence similarity 3, member C/interleukin-like EMT-inducer. Our findings demonstrate a previously unreported molecular pathway for SPARC activity on invasion and support an active role of SPARC in the mesenchymal transformation that contributes to melanoma dissemination. In melanoma, the extracellular protein SPARC (secreted protein acidic and rich in cysteine) is related to tumor progression. Some of the evidence that links SPARC to melanoma progression indicates that SPARC may be involved in the acquisition of mesenchymal traits that favor metastatic dissemination. However, no molecular pathways that link extracellular SPARC to a mesenchymal phenotype have been described. In this study, global protein expression analysis of the melanoma secretome following enforced downregulation of SPARC expression led us to elucidate a new molecular mechanism by which SPARC promotes cathepsin B-mediated melanoma invasiveness using collagen I and α2β1 integrins as mediators. Interestingly, we also found that the transforming growth factor (TGF)-β1 contribution to cathepsin B-mediated invasion is highly SPARC dependent. In addition, induction of the E-cadherin to N-cadherin switch by SPARC enabled melanoma cells to transmigrate across an endothelial layer through a mechanism independent to that of enhancing invasion. Finally, SPARC also enhanced the extracellular expression of other proteins involved in epithelial-mesenchymal transformation, such as family with sequence similarity 3, member C/interleukin-like EMT-inducer. Our findings demonstrate a previously unreported molecular pathway for SPARC activity on invasion and support an active role of SPARC in the mesenchymal transformation that contributes to melanoma dissemination.In melanoma, the extracellular protein SPARC (secreted protein acidic and rich in cysteine) is related to tumor progression. Some of the evidence that links SPARC to melanoma progression indicates that SPARC may be involved in the acquisition of mesenchymal traits that favor metastatic dissemination. However, no molecular pathways that link extracellular SPARC to a mesenchymal phenotype have been described. In this study, global protein expression analysis of the melanoma secretome following enforced downregulation of SPARC expression led us to elucidate a new molecular mechanism by which SPARC promotes cathepsin B-mediated melanoma invasiveness using collagen I and α2β1 integrins as mediators. Interestingly, we also found that the transforming growth factor (TGF)-β1 contribution to cathepsin B-mediated invasion is highly SPARC dependent. In addition, induction of the E-cadherin to N-cadherin switch by SPARC enabled melanoma cells to transmigrate across an endothelial layer through a mechanism independent to that of enhancing invasion. Finally, SPARC also enhanced the extracellular expression of other proteins involved in epithelial-mesenchymal transformation, such as family with sequence similarity 3, member C/interleukin-like EMT-inducer. Our findings demonstrate a previously unreported molecular pathway for SPARC activity on invasion and support an active role of SPARC in the mesenchymal transformation that contributes to melanoma dissemination. |
Author | Albar, Juan P. Camafeita, Emilio López, Juan A. Valacco, María P. Brekken, Rolf A. Fernández, Marisol Llera, Andrea S. Girotti, María R. Benedetti, Lorena G. Podhajcer, Osvaldo L. Fernández, Elmer A. |
Author_xml | – sequence: 1 givenname: María R. surname: Girotti fullname: Girotti, María R. organization: Laboratory of Molecular and Cellular Therapy, Fundación Instituto Leloir-CONICET, Buenos Aires, Argentina – sequence: 2 givenname: Marisol surname: Fernández fullname: Fernández, Marisol organization: Proteomics Unit, Centro Nacional de Biotecnología-CSIC, Madrid, Spain – sequence: 3 givenname: Juan A. surname: López fullname: López, Juan A. organization: Proteomics Unit, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain – sequence: 4 givenname: Emilio surname: Camafeita fullname: Camafeita, Emilio organization: Proteomics Unit, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain – sequence: 5 givenname: Elmer A. surname: Fernández fullname: Fernández, Elmer A. organization: Intelligent Data Analysis Group, School of Engineering, Universidad Católica de Córdoba, Córdoba, Argentina – sequence: 6 givenname: Juan P. surname: Albar fullname: Albar, Juan P. organization: Proteomics Unit, Centro Nacional de Biotecnología-CSIC, Madrid, Spain – sequence: 7 givenname: Lorena G. surname: Benedetti fullname: Benedetti, Lorena G. organization: Laboratory of Molecular and Cellular Therapy, Fundación Instituto Leloir-CONICET, Buenos Aires, Argentina – sequence: 8 givenname: María P. surname: Valacco fullname: Valacco, María P. organization: Laboratory of Molecular and Cellular Therapy, Fundación Instituto Leloir-CONICET, Buenos Aires, Argentina – sequence: 9 givenname: Rolf A. surname: Brekken fullname: Brekken, Rolf A. organization: Division of Surgical Oncology, Department of Surgery, Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas, USA – sequence: 10 givenname: Osvaldo L. surname: Podhajcer fullname: Podhajcer, Osvaldo L. organization: Laboratory of Molecular and Cellular Therapy, Fundación Instituto Leloir-CONICET, Buenos Aires, Argentina – sequence: 11 givenname: Andrea S. surname: Llera fullname: Llera, Andrea S. email: allera@leloir.org.ar organization: Laboratory of Molecular and Cellular Therapy, Fundación Instituto Leloir-CONICET, Buenos Aires, Argentina |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24819322$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/21850018$$D View this record in MEDLINE/PubMed |
BookMark | eNp10V1rFDEUBuAgLXZbvfNa5ka8cbb5mpnM5TpUXWix-AHehUzmZDdlJtkm2aX-LP0h_U2m7FpB9CoceN5DOO8pOnLeAUIvCJ4TzMT5jR3mFBMyp6x9gmakoqwkDW-O0AxjSkuK6bcTdBrjDcak5pV4ik4oEVWexAzpz9eLT11xHfzkE8SiU2kNm2hd8ba8gsGqBENxBaNyflLF0u1UtDtwEGOR1sFvV-tCFZ0fR7UCVyzP73_Q-58kwwSrkLcs7mx8ho6NGiM8P7xn6Ou7iy_dh_Ly4_tlt7gsNW9IKomg3GhiAAxlfd82qmqVFkYz1WsulOacD1RxYLxnWNeYVKKpK4HFgE1lDDtDr_d7N8HfbiEmOdmoIf_Ngd9G2WJWV03NRJYvD3LbTzDITbCTCt_l77tk8OoAVNRqNEE5beMfxwVpGaXZvdk7HXyMAcwjIVg-1CNzPfKhHpnryZz-xbVNKlnvUlB2_F-o3ocg325nIcioLTid2wmgkxy8_XfwF3BmpaI |
CODEN | JIDEAE |
CitedBy_id | crossref_primary_10_3390_cancers14194921 crossref_primary_10_1007_s13277_014_2315_0 crossref_primary_10_1515_hmbci_2015_0001 crossref_primary_10_1002_biof_1442 crossref_primary_10_2217_bmm_2020_0179 crossref_primary_10_3389_fbioe_2020_601969 crossref_primary_10_3389_fonc_2022_924553 crossref_primary_10_1016_j_pharmthera_2019_02_003 crossref_primary_10_1074_jbc_M111_317727 crossref_primary_10_1186_s12885_021_07875_9 crossref_primary_10_3390_cells11091455 crossref_primary_10_1093_carcin_bgu072 crossref_primary_10_3389_fonc_2022_914156 crossref_primary_10_1186_s12967_019_2058_1 crossref_primary_10_1016_j_compbiomed_2011_11_007 crossref_primary_10_1134_S0006297918060111 crossref_primary_10_3390_ijms23115874 crossref_primary_10_1016_j_jid_2021_10_007 crossref_primary_10_3389_fonc_2021_690460 crossref_primary_10_3389_fimmu_2023_1269700 crossref_primary_10_5966_sctm_2013_0031 crossref_primary_10_1016_j_yexmp_2019_104276 crossref_primary_10_1007_s12032_015_0515_0 crossref_primary_10_1002_dvdy_24557 crossref_primary_10_3389_fmolb_2023_1235428 crossref_primary_10_3389_fonc_2015_00036 crossref_primary_10_3892_ol_2016_4399 crossref_primary_10_1080_14789450_2017_1353913 crossref_primary_10_1002_path_4535 crossref_primary_10_3109_1547691X_2012_723767 crossref_primary_10_4161_cc_23274 crossref_primary_10_3389_fimmu_2025_1513750 crossref_primary_10_1093_bbb_zbae177 crossref_primary_10_1080_22311866_2024_2312835 crossref_primary_10_1002_jcb_24600 crossref_primary_10_3389_fphar_2024_1329636 crossref_primary_10_5021_ad_2013_25_2_135 crossref_primary_10_1152_physiolgenomics_00158_2013 crossref_primary_10_1002_prca_201300105 crossref_primary_10_1007_s12195_023_00787_7 crossref_primary_10_1002_ijc_28765 crossref_primary_10_1038_bjc_2015_358 crossref_primary_10_33808_clinexphealthsci_1100770 crossref_primary_10_1016_j_ebiom_2019_11_003 crossref_primary_10_1186_1471_2407_12_464 crossref_primary_10_18632_oncotarget_24085 crossref_primary_10_1007_s13277_014_2633_2 crossref_primary_10_3390_ijms231911722 crossref_primary_10_3390_ijms21218193 crossref_primary_10_1007_s13577_023_01020_3 crossref_primary_10_1016_j_jprot_2012_10_016 crossref_primary_10_2217_fon_15_176 crossref_primary_10_1517_14728222_2013_740461 crossref_primary_10_3389_fonc_2020_01620 crossref_primary_10_1002_jcp_28205 crossref_primary_10_1002_pros_22664 |
Cites_doi | 10.2217/fon.09.90 10.1002/ijc.23039 10.1093/nar/gkg115 10.1158/0008-5472.CAN-05-3189 10.1016/j.tcb.2008.05.002 10.1007/s12253-009-9175-8 10.1016/j.ceb.2010.08.015 10.1593/neo.08178 10.1074/jbc.M409101200 10.1002/ijc.21700 10.1074/jbc.272.14.9237 10.1038/sj.jid.5700962 10.1074/jbc.M706563200 10.1002/pmic.200700255 10.1158/0008-5472.CAN-04-1102 10.1016/S1357-4310(00)01692-0 10.1038/nprot.2009.152 10.1002/jcp.1041580121 10.1083/jcb.200708137 10.1172/JCI12939 10.1101/gr.772403 10.1016/j.cell.2009.10.027 10.1002/art.21973 10.1038/nbt0310-214 10.1111/1523-1747.ep12334263 10.1046/j.1432-1327.1999.00582.x 10.1186/gb-2006-7-10-r100 10.1016/j.cell.2009.11.007 10.1016/S0046-8177(99)90014-X 10.1016/S0945-053X(00)00133-5 10.1038/sj.onc.1210181 10.1124/mol.62.1.58 10.1158/0008-5472.CAN-06-3481 10.1074/jbc.274.45.32145 10.1016/0925-4439(94)90018-3 10.1038/nm0297-171 10.1093/neuonc/noq048 10.1038/sj.onc.1210593 10.1021/bi00014a037 10.1515/BC.2007.072 10.1038/nrc1949 10.1007/s10555-008-9146-7 10.1046/j.1523-1755.2000.00811.x 10.1111/j.1755-148X.2010.00790.x 10.1074/jbc.M204708200 10.1634/stemcells.2008-0212 10.1091/mbc.e03-01-0001 10.1016/S0736-5748(99)00009-X 10.1056/NEJMra041245 10.1046/j.1523-1747.2003.12241.x 10.1021/ac051349d 10.1074/jbc.M710001200 10.1023/A:1023007717757 |
ContentType | Journal Article |
Copyright | 2011 The Society for Investigative Dermatology, Inc 2015 INIST-CNRS |
Copyright_xml | – notice: 2011 The Society for Investigative Dermatology, Inc – notice: 2015 INIST-CNRS |
DBID | 6I. AAFTH AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1038/jid.2011.239 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1523-1747 |
EndPage | 2447 |
ExternalDocumentID | 21850018 24819322 10_1038_jid_2011_239 S0022202X15351022 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- --K .55 .GJ 0R~ 1B1 29K 2WC 36B 3O- 4.4 457 53G 5GY 5RE 5VS 6I. 7X7 88E 8AO 8FI 8FJ 8R4 8R5 AACTN AAEDW AAFTH AALRI AAXUO ABAWZ ABJNI ABLJU ABMAC ABUWG ACGFO ACGFS ACPRK ADBBV ADEZE ADFRT ADVLN AENEX AEXQZ AFEBI AFETI AFFNX AFJKZ AFKRA AFTJW AGHFR AHMBA AI. AITUG AKRWK ALIPV ALMA_UNASSIGNED_HOLDINGS AMRAJ APXCP BAWUL BENPR BFHJK BPHCQ BVXVI CAG CCPQU COF CS3 D-I DIK E3Z EBS EJD F5P FDB FRP FYUFA GX1 HMCUK HZ~ IH2 IHE J5H JSO KQ8 L7B LH4 LW6 M1P M41 MVM NQ- O9- OK1 P2P PHGZT PQQKQ PROAC PSQYO Q2X R9- RIG RNS ROL RPZ SSZ TR2 UKHRP VH1 W2D X7M Y6R YFH YOC YUY ZGI AAFWJ AAYWO AAYXX ACVFH ADCNI AEUPX AFPUW AGCQF AIGII AKBMS AKYEP CITATION PHGZM EFKBS IQODW PJZUB PPXIY CGR CUY CVF ECM EIF NPM 7X8 PUEGO |
ID | FETCH-LOGICAL-c471t-1824fc1feef23bb97a59ac8fc3abc48ac444d2a4e34b30c60158765808d0f5ff3 |
ISSN | 0022-202X 1523-1747 |
IngestDate | Sun Aug 24 03:53:04 EDT 2025 Thu Apr 03 07:06:18 EDT 2025 Mon Jul 21 09:14:45 EDT 2025 Tue Jul 01 05:15:31 EDT 2025 Thu Apr 24 23:12:35 EDT 2025 Sat Apr 12 15:20:51 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Keywords | Integrin Malignant tumor Dermatology Collagen Malignant melanoma Cancer |
Language | English |
License | http://www.elsevier.com/open-access/userlicense/1.0 CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c471t-1824fc1feef23bb97a59ac8fc3abc48ac444d2a4e34b30c60158765808d0f5ff3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://dx.doi.org/10.1038/jid.2011.239 |
PMID | 21850018 |
PQID | 903657638 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_903657638 pubmed_primary_21850018 pascalfrancis_primary_24819322 crossref_primary_10_1038_jid_2011_239 crossref_citationtrail_10_1038_jid_2011_239 elsevier_sciencedirect_doi_10_1038_jid_2011_239 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2011-12-01 |
PublicationDateYYYYMMDD | 2011-12-01 |
PublicationDate_xml | – month: 12 year: 2011 text: 2011-12-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | New York, NY |
PublicationPlace_xml | – name: New York, NY – name: United States |
PublicationTitle | Journal of investigative dermatology |
PublicationTitleAlternate | J Invest Dermatol |
PublicationYear | 2011 |
Publisher | Elsevier Inc Nature Publishing Group |
Publisher_xml | – name: Elsevier Inc – name: Nature Publishing Group |
References | Wendt, Allington, Schiemann (bb0270) 2009; 5 Weaver, Workman, Sage (bb0265) 2008; 283 Ledda, Adris, Bravo (bb0110) 1997; 3 Zhou, Tan, Guo (bb0280) 2006; 54 Bradshaw, Puolakkainen, Dasgupta (bb0035) 2003; 120 Reisenauer, Eickelberg, Wille (bb0180) 2007; 388 Laping, Grygielko, Mathur (bb0100) 2002; 62 Keppler, Waridel, Abrahamson (bb0085) 1994; 1226 Mohamed, Sloane (bb0150) 2006; 6 Thomas, Alam, Lemke (bb0245) 2010; 12 Sosa, Girotti, Salvatierra (bb0225) 2007; 7 Fenouille, Robert, Tichet (bb0055) 2011; 24 Prada, Benedetti, Bravo (bb0170) 2007; 127 Shintani, Fukumoto, Chaika (bb0215) 2008; 180 Giudici, Raynal, Wiedemann (bb0065) 2008; 283 Carpenter, Jones, Lamprecht (bb0045) 2006; 7 Tsao, Atkins, Sober (bb0250) 2004; 351 Egeblad, Rasch, Weaver (bb0050) 2010; 22 West, Welch, Gatecki (bb0275) 2007 Schiemann, Neil, Schiemann (bb0200) 2003; 14 Thomas, Campbell, Kejariwal (bb0235) 2003; 13 Lien, Hsiao, Lin (bb0130) 2007; 26 Brekken, Sage (bb0040) 2001; 19 Koblinski, Dosescu, Sameni (bb0095) 2002; 277 Assoian, Klein (bb0020) 2008; 18 Moreno-Bueno, Peinado, Molina (bb0155) 2009; 4 Smit, Gardiner, Sturm (bb0220) 2007; 121 Francki, Bradshaw, Bassuk (bb0060) 1999; 274 Golembieski, Ge, Nelson (bb0080) 1999; 17 Turk, Podobnik, Popovic (bb0255) 1995; 34 Klose, Wilbrand-Hennes, Zigrino (bb0090) 2006; 118 Linebaugh, Sameni, Day (bb0135) 1999; 264 Wang, Fertala, Ratner (bb0260) 2005; 77 Bassuk, Pichler, Rothmier (bb0025) 2000; 57 Lee, Kang, Chong (bb0115) 2005; 280 Sasaki, Gohring, Mann (bb0195) 1997; 272 Alvarez, Prada, Salvatierra (bb0015) 2005; 65 Mack, Marshall (bb0140) 2010; 28 Ledda, Bravo, Adris (bb0105) 1997; 108 Bradshaw, Sage (bb0030) 2001; 107 Nie, Chang, Traktuev (bb0160) 2008; 26 Shi, Bao, Song (bb0210) 2007; 26 Robert, Gaggioli, Bailet (bb0185) 2006; 66 Massi, Franchi, Borgognoni (bb0145) 1999; 30 Reed, Vernon, Abrass (bb0175) 1994; 158 Thiery, Acloque, Huang (bb0230) 2009; 139 Alonso, Tracey, Ortiz (bb0010) 2007; 67 Li, Herlyn (bb0125) 2000; 6 Thomas, Kejariwal, Campbell (bb0240) 2003; 31 Podhajcer, Benedetti, Girotti (bb0165) 2008; 27 Roshy, Sloane, Moin (bb0190) 2003; 22 Schultz, Lemke, Ge (bb0205) 2002; 62 Gole, Duran Alonso, Dolenc (bb0075) 2009; 15 Levental, Yu, Kass (bb0120) 2009; 139 Giusti, D′Ascenzo, Millimaggi (bb0070) 2008; 10 Ledda (10.1038/jid.2011.239_bb0110) 1997; 3 Schultz (10.1038/jid.2011.239_bb0205) 2002; 62 Weaver (10.1038/jid.2011.239_bb0265) 2008; 283 West (10.1038/jid.2011.239_bb0275) 2007 Bradshaw (10.1038/jid.2011.239_bb0035) 2003; 120 Thomas (10.1038/jid.2011.239_bb0245) 2010; 12 Podhajcer (10.1038/jid.2011.239_bb0165) 2008; 27 Giusti (10.1038/jid.2011.239_bb0070) 2008; 10 Schiemann (10.1038/jid.2011.239_bb0200) 2003; 14 Fenouille (10.1038/jid.2011.239_bb0055) 2011; 24 Giudici (10.1038/jid.2011.239_bb0065) 2008; 283 Golembieski (10.1038/jid.2011.239_bb0080) 1999; 17 Bradshaw (10.1038/jid.2011.239_bb0030) 2001; 107 Moreno-Bueno (10.1038/jid.2011.239_bb0155) 2009; 4 Assoian (10.1038/jid.2011.239_bb0020) 2008; 18 Li (10.1038/jid.2011.239_bb0125) 2000; 6 Robert (10.1038/jid.2011.239_bb0185) 2006; 66 Nie (10.1038/jid.2011.239_bb0160) 2008; 26 Lee (10.1038/jid.2011.239_bb0115) 2005; 280 Sosa (10.1038/jid.2011.239_bb0225) 2007; 7 Egeblad (10.1038/jid.2011.239_bb0050) 2010; 22 Alvarez (10.1038/jid.2011.239_bb0015) 2005; 65 Tsao (10.1038/jid.2011.239_bb0250) 2004; 351 Francki (10.1038/jid.2011.239_bb0060) 1999; 274 Wendt (10.1038/jid.2011.239_bb0270) 2009; 5 Carpenter (10.1038/jid.2011.239_bb0045) 2006; 7 Shintani (10.1038/jid.2011.239_bb0215) 2008; 180 Linebaugh (10.1038/jid.2011.239_bb0135) 1999; 264 Smit (10.1038/jid.2011.239_bb0220) 2007; 121 Thomas (10.1038/jid.2011.239_bb0235) 2003; 13 Roshy (10.1038/jid.2011.239_bb0190) 2003; 22 Bassuk (10.1038/jid.2011.239_bb0025) 2000; 57 Massi (10.1038/jid.2011.239_bb0145) 1999; 30 Koblinski (10.1038/jid.2011.239_bb0095) 2002; 277 Mack (10.1038/jid.2011.239_bb0140) 2010; 28 Shi (10.1038/jid.2011.239_bb0210) 2007; 26 Keppler (10.1038/jid.2011.239_bb0085) 1994; 1226 Wang (10.1038/jid.2011.239_bb0260) 2005; 77 Thomas (10.1038/jid.2011.239_bb0240) 2003; 31 Turk (10.1038/jid.2011.239_bb0255) 1995; 34 Zhou (10.1038/jid.2011.239_bb0280) 2006; 54 Alonso (10.1038/jid.2011.239_bb0010) 2007; 67 Levental (10.1038/jid.2011.239_bb0120) 2009; 139 Lien (10.1038/jid.2011.239_bb0130) 2007; 26 Ledda (10.1038/jid.2011.239_bb0105) 1997; 108 Prada (10.1038/jid.2011.239_bb0170) 2007; 127 Laping (10.1038/jid.2011.239_bb0100) 2002; 62 Klose (10.1038/jid.2011.239_bb0090) 2006; 118 Brekken (10.1038/jid.2011.239_bb0040) 2001; 19 Gole (10.1038/jid.2011.239_bb0075) 2009; 15 Reisenauer (10.1038/jid.2011.239_bb0180) 2007; 388 Sasaki (10.1038/jid.2011.239_bb0195) 1997; 272 Thiery (10.1038/jid.2011.239_bb0230) 2009; 139 Mohamed (10.1038/jid.2011.239_bb0150) 2006; 6 Reed (10.1038/jid.2011.239_bb0175) 1994; 158 |
References_xml | – volume: 158 start-page: 169 year: 1994 end-page: 179 ident: bb0175 article-title: TGF-beta 1 induces the expression of type I collagen and SPARC, and enhances contraction of collagen gels, by fibroblasts from young and aged donors publication-title: J Cell Physiol – volume: 7 start-page: 4123 year: 2007 end-page: 4134 ident: bb0225 article-title: Proteomic analysis identified N-cadherin, clusterin, and HSP27 as mediators of SPARC (secreted protein, acidic and rich in cysteines) activity in melanoma cells publication-title: Proteomics – volume: 1226 start-page: 117 year: 1994 end-page: 125 ident: bb0085 article-title: Latency of cathepsin B secreted by human colon carcinoma cells is not linked to secretion of cystatin C and is relieved by neutrophil elastase publication-title: Biochim Biophys Acta – volume: 3 start-page: 171 year: 1997 end-page: 176 ident: bb0110 article-title: Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells publication-title: Nat Med – volume: 118 start-page: 2735 year: 2006 end-page: 2743 ident: bb0090 article-title: Contact of high-invasive, but not low-invasive, melanoma cells to native collagen I induces the release of mature cathepsin B publication-title: Int J Cancer – volume: 14 start-page: 3977 year: 2003 end-page: 3988 ident: bb0200 article-title: SPARC inhibits epithelial cell proliferation in part through stimulation of the transforming growth factor-beta-signaling system publication-title: Mol Biol Cell – volume: 283 start-page: 22826 year: 2008 end-page: 22837 ident: bb0265 article-title: The copper-binding domain of sparc mediates cell survival publication-title: J Biol Chem – volume: 65 start-page: 5123 year: 2005 end-page: 5132 ident: bb0015 article-title: Secreted protein acidic and rich in cysteine produced by human melanoma cells modulates polymorphonuclear leukocyte recruitment and antitumor cytotoxic capacity publication-title: Cancer Res – volume: 6 start-page: 764 year: 2006 end-page: 775 ident: bb0150 article-title: Cysteine cathepsins: multifunctional enzymes in cancer publication-title: Nat Rev Cancer – volume: 264 start-page: 100 year: 1999 end-page: 109 ident: bb0135 article-title: Exocytosis of active cathepsin B enzyme activity at pH 7.0, inhibition and molecular mass publication-title: Eur J Biochem – volume: 34 start-page: 4791 year: 1995 end-page: 4797 ident: bb0255 article-title: Crystal structure of cathepsin B inhibited with CA030 at 2.0-A resolution: A basis for the design of specific epoxysuccinyl inhibitors publication-title: Biochemistry – volume: 4 start-page: 1591 year: 2009 end-page: 1613 ident: bb0155 article-title: The morphological and molecular features of the epithelial-to-mesenchymal transition publication-title: Nat Protoc – volume: 388 start-page: 639 year: 2007 end-page: 650 ident: bb0180 article-title: Increased carcinogenic potential of myeloid tumor cells induced by aberrant TGF-beta1-signaling and upregulation of cathepsin B publication-title: Biol Chem – volume: 57 start-page: 117 year: 2000 end-page: 128 ident: bb0025 article-title: Induction of TGF-beta1 by the matricellular protein SPARC in a rat model of glomerulonephritis publication-title: Kidney Int – volume: 274 start-page: 32145 year: 1999 end-page: 32152 ident: bb0060 article-title: SPARC regulates the expression of collagen type I and transforming growth factor-beta1 in mesangial cells publication-title: J Biol Chem – volume: 351 start-page: 998 year: 2004 end-page: 1012 ident: bb0250 article-title: Management of cutaneous melanoma publication-title: N Engl J Med – volume: 17 start-page: 463 year: 1999 end-page: 472 ident: bb0080 article-title: Increased SPARC expression promotes U87 glioblastoma invasion publication-title: Int J Dev Neurosci – volume: 26 start-page: 2735 year: 2008 end-page: 2745 ident: bb0160 article-title: IFATS collection: combinatorial peptides identify alpha5beta1 integrin as a receptor for the matricellular protein SPARC on adipose stromal cells publication-title: Stem Cells – volume: 18 start-page: 347 year: 2008 end-page: 352 ident: bb0020 article-title: Growth control by intracellular tension and extracellular stiffness publication-title: Trends Cell Biol – volume: 22 start-page: 271 year: 2003 end-page: 286 ident: bb0190 article-title: Pericellular cathepsin B and malignant progression publication-title: Cancer Metastasis Rev – volume: 15 start-page: 711 year: 2009 end-page: 723 ident: bb0075 article-title: Post-translational regulation of cathepsin B, but not of other cysteine cathepsins, contributes to increased glioblastoma cell invasiveness publication-title: Pathol Oncol Res – volume: 6 start-page: 163 year: 2000 end-page: 169 ident: bb0125 article-title: Dynamics of intercellular communication during melanoma development publication-title: Mol Med Today – volume: 283 start-page: 19551 year: 2008 end-page: 19560 ident: bb0065 article-title: Mapping of SPARC/BM-40/osteonectin-binding sites on fibrillar collagens publication-title: J Biol Chem – volume: 108 start-page: 210 year: 1997 end-page: 214 ident: bb0105 article-title: The expression of the secreted protein acidic and rich in cysteine (SPARC) is associated with the neoplastic progression of human melanoma publication-title: J Invest Dermatol – volume: 280 start-page: 7845 year: 2005 end-page: 7853 ident: bb0115 article-title: The amyloid-beta peptide suppresses transforming growth factor-beta1-induced matrix metalloproteinase-2 production via Smad7 expression in human monocytic THP-1 cells publication-title: J Biol Chem – volume: 120 start-page: 949 year: 2003 end-page: 955 ident: bb0035 article-title: SPARC-null mice display abnormalities in the dermis characterized by decreased collagen fibril diameter and reduced tensile strength publication-title: J Invest Dermatol – volume: 121 start-page: 2653 year: 2007 end-page: 2660 ident: bb0220 article-title: Osteonectin downregulates E-cadherin, induces osteopontin and focal adhesion kinase activity stimulating an invasive melanoma phenotype publication-title: Int J Cancer – volume: 13 start-page: 2129 year: 2003 end-page: 2141 ident: bb0235 article-title: PANTHER: a library of protein families and subfamilies indexed by function publication-title: Genome Res – volume: 19 start-page: 816 year: 2001 end-page: 827 ident: bb0040 article-title: SPARC, a matricellular protein: at the crossroads of cell-matrix communication publication-title: Matrix Biol – volume: 26 start-page: 4084 year: 2007 end-page: 4094 ident: bb0210 article-title: Targeting SPARC expression decreases glioma cellular survival and invasion associated with reduced activities of FAK and ILK kinases publication-title: Oncogene – volume: 139 start-page: 871 year: 2009 end-page: 890 ident: bb0230 article-title: Epithelial-mesenchymal transitions in development and disease publication-title: Cell – volume: 7 start-page: R100 year: 2006 ident: bb0045 article-title: CellProfiler: image analysis software for identifying and quantifying cell phenotypes publication-title: Genome Biol – volume: 24 start-page: 219 year: 2011 end-page: 232 ident: bb0055 article-title: The p53/p21Cip1/ Waf1 pathway mediates the effects of SPARC on melanoma cell cycle progression publication-title: Pigment Cell Melanoma Res – volume: 5 start-page: 1145 year: 2009 end-page: 1168 ident: bb0270 article-title: Mechanisms of the epithelial-mesenchymal transition by TGF-beta publication-title: Future Oncol – volume: 28 start-page: 214 year: 2010 end-page: 229 ident: bb0140 article-title: Lost in migration publication-title: Nat Biotechnol – volume: 272 start-page: 9237 year: 1997 end-page: 9243 ident: bb0195 article-title: Limited cleavage of extracellular matrix protein BM-40 by matrix metalloproteinases increases its affinity for collagens publication-title: J Biol Chem – volume: 62 start-page: 6270 year: 2002 end-page: 6277 ident: bb0205 article-title: Secreted protein acidic and rich in cysteine promotes glioma invasion and delays tumor growth publication-title: Cancer Res – volume: 180 start-page: 1277 year: 2008 end-page: 1289 ident: bb0215 article-title: Collagen I-mediated up-regulation of N-cadherin requires cooperative signals from integrins and discoidin domain receptor 1 publication-title: J Cell Biol – volume: 77 start-page: 6765 year: 2005 end-page: 6771 ident: bb0260 article-title: Identifying the SPARC binding sites on collagen I and procollagen I by atomic force microscopy publication-title: Anal Chem – volume: 62 start-page: 58 year: 2002 end-page: 64 ident: bb0100 article-title: Inhibition of transforming growth factor (TGF)-beta 1-induced extracellular matrix with a novel inhibitor of the TGF-beta Type I receptor kinase activity: SB-431542 publication-title: Mol Pharmacol – volume: 54 start-page: 2626 year: 2006 end-page: 2631 ident: bb0280 article-title: Attenuation of collagen production with small interfering RNA of SPARC in cultured fibroblasts from the skin of patients with scleroderma publication-title: Arthritis Rheum – volume: 139 start-page: 891 year: 2009 end-page: 906 ident: bb0120 article-title: Matrix crosslinking forces tumor progression by enhancing integrin signaling publication-title: Cell – volume: 31 start-page: 334 year: 2003 end-page: 341 ident: bb0240 article-title: PANTHER: a browsable database of gene products organized by biological function, using curated protein family and subfamily classification publication-title: Nucleic Acids Res – year: 2007 ident: bb0275 publication-title: Linear Mixed Models: A Practical Guide Using Statistical Software – volume: 27 start-page: 691 year: 2008 end-page: 705 ident: bb0165 article-title: The role of the matricellular protein SPARC in the dynamic interaction between the tumor and the host publication-title: Cancer Metastasis Rev – volume: 127 start-page: 2618 year: 2007 end-page: 2628 ident: bb0170 article-title: SPARC endogenous level, rather than fibroblast-produced SPARC or stroma reorganization induced by SPARC, is responsible for melanoma cell growth publication-title: J Invest Dermatol – volume: 67 start-page: 3450 year: 2007 end-page: 3460 ident: bb0010 article-title: A high-throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasis publication-title: Cancer Res – volume: 26 start-page: 7859 year: 2007 end-page: 7871 ident: bb0130 article-title: Molecular signatures of metaplastic carcinoma of the breast by large-scale transcriptional profiling: identification of genes potentially related to epithelial-mesenchymal transition publication-title: Oncogene – volume: 66 start-page: 7516 year: 2006 end-page: 7523 ident: bb0185 article-title: SPARC represses E-cadherin and induces mesenchymal transition during melanoma development publication-title: Cancer Res – volume: 22 start-page: 697 year: 2010 end-page: 706 ident: bb0050 article-title: Dynamic interplay between the collagen scaffold and tumor evolution publication-title: Curr Opin Cell Biol – volume: 10 start-page: 481 year: 2008 end-page: 488 ident: bb0070 article-title: Cathepsin B mediates the pH-dependent proinvasive activity of tumor-shed microvesicles publication-title: Neoplasia – volume: 12 start-page: 941 year: 2010 end-page: 955 ident: bb0245 article-title: PTEN augments SPARC suppression of proliferation and inhibits SPARC-induced migration by suppressing SHC-RAF-ERK and AKT signaling publication-title: Neuro Oncol – volume: 30 start-page: 339 year: 1999 end-page: 344 ident: bb0145 article-title: Osteonectin expression correlates with clinical outcome in thin cutaneous malignant melanomas publication-title: Hum Pathol – volume: 277 start-page: 32220 year: 2002 end-page: 32227 ident: bb0095 article-title: Interaction of human breast fibroblasts with collagen I increases secretion of procathepsin B publication-title: J Biol Chem – volume: 107 start-page: 1049 year: 2001 end-page: 1054 ident: bb0030 article-title: SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury publication-title: J Clin Invest – volume: 5 start-page: 1145 year: 2009 ident: 10.1038/jid.2011.239_bb0270 article-title: Mechanisms of the epithelial-mesenchymal transition by TGF-beta publication-title: Future Oncol doi: 10.2217/fon.09.90 – volume: 62 start-page: 6270 year: 2002 ident: 10.1038/jid.2011.239_bb0205 article-title: Secreted protein acidic and rich in cysteine promotes glioma invasion and delays tumor growth in vivo publication-title: Cancer Res – volume: 121 start-page: 2653 year: 2007 ident: 10.1038/jid.2011.239_bb0220 article-title: Osteonectin downregulates E-cadherin, induces osteopontin and focal adhesion kinase activity stimulating an invasive melanoma phenotype publication-title: Int J Cancer doi: 10.1002/ijc.23039 – volume: 31 start-page: 334 year: 2003 ident: 10.1038/jid.2011.239_bb0240 article-title: PANTHER: a browsable database of gene products organized by biological function, using curated protein family and subfamily classification publication-title: Nucleic Acids Res doi: 10.1093/nar/gkg115 – volume: 66 start-page: 7516 year: 2006 ident: 10.1038/jid.2011.239_bb0185 article-title: SPARC represses E-cadherin and induces mesenchymal transition during melanoma development publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-05-3189 – volume: 18 start-page: 347 year: 2008 ident: 10.1038/jid.2011.239_bb0020 article-title: Growth control by intracellular tension and extracellular stiffness publication-title: Trends Cell Biol doi: 10.1016/j.tcb.2008.05.002 – volume: 15 start-page: 711 year: 2009 ident: 10.1038/jid.2011.239_bb0075 article-title: Post-translational regulation of cathepsin B, but not of other cysteine cathepsins, contributes to increased glioblastoma cell invasiveness in vitro publication-title: Pathol Oncol Res doi: 10.1007/s12253-009-9175-8 – volume: 22 start-page: 697 year: 2010 ident: 10.1038/jid.2011.239_bb0050 article-title: Dynamic interplay between the collagen scaffold and tumor evolution publication-title: Curr Opin Cell Biol doi: 10.1016/j.ceb.2010.08.015 – volume: 10 start-page: 481 year: 2008 ident: 10.1038/jid.2011.239_bb0070 article-title: Cathepsin B mediates the pH-dependent proinvasive activity of tumor-shed microvesicles publication-title: Neoplasia doi: 10.1593/neo.08178 – volume: 280 start-page: 7845 year: 2005 ident: 10.1038/jid.2011.239_bb0115 article-title: The amyloid-beta peptide suppresses transforming growth factor-beta1-induced matrix metalloproteinase-2 production via Smad7 expression in human monocytic THP-1 cells publication-title: J Biol Chem doi: 10.1074/jbc.M409101200 – volume: 118 start-page: 2735 year: 2006 ident: 10.1038/jid.2011.239_bb0090 article-title: Contact of high-invasive, but not low-invasive, melanoma cells to native collagen I induces the release of mature cathepsin B publication-title: Int J Cancer doi: 10.1002/ijc.21700 – volume: 272 start-page: 9237 year: 1997 ident: 10.1038/jid.2011.239_bb0195 article-title: Limited cleavage of extracellular matrix protein BM-40 by matrix metalloproteinases increases its affinity for collagens publication-title: J Biol Chem doi: 10.1074/jbc.272.14.9237 – volume: 127 start-page: 2618 year: 2007 ident: 10.1038/jid.2011.239_bb0170 article-title: SPARC endogenous level, rather than fibroblast-produced SPARC or stroma reorganization induced by SPARC, is responsible for melanoma cell growth publication-title: J Invest Dermatol doi: 10.1038/sj.jid.5700962 – volume: 283 start-page: 22826 year: 2008 ident: 10.1038/jid.2011.239_bb0265 article-title: The copper-binding domain of sparc mediates cell survival in vitro via interaction with integrin beta 1 and activation of integrin-linked kinase publication-title: J Biol Chem doi: 10.1074/jbc.M706563200 – volume: 7 start-page: 4123 year: 2007 ident: 10.1038/jid.2011.239_bb0225 article-title: Proteomic analysis identified N-cadherin, clusterin, and HSP27 as mediators of SPARC (secreted protein, acidic and rich in cysteines) activity in melanoma cells publication-title: Proteomics doi: 10.1002/pmic.200700255 – volume: 65 start-page: 5123 year: 2005 ident: 10.1038/jid.2011.239_bb0015 article-title: Secreted protein acidic and rich in cysteine produced by human melanoma cells modulates polymorphonuclear leukocyte recruitment and antitumor cytotoxic capacity publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-04-1102 – volume: 6 start-page: 163 year: 2000 ident: 10.1038/jid.2011.239_bb0125 article-title: Dynamics of intercellular communication during melanoma development publication-title: Mol Med Today doi: 10.1016/S1357-4310(00)01692-0 – volume: 4 start-page: 1591 year: 2009 ident: 10.1038/jid.2011.239_bb0155 article-title: The morphological and molecular features of the epithelial-to-mesenchymal transition publication-title: Nat Protoc doi: 10.1038/nprot.2009.152 – volume: 158 start-page: 169 year: 1994 ident: 10.1038/jid.2011.239_bb0175 article-title: TGF-beta 1 induces the expression of type I collagen and SPARC, and enhances contraction of collagen gels, by fibroblasts from young and aged donors publication-title: J Cell Physiol doi: 10.1002/jcp.1041580121 – volume: 180 start-page: 1277 year: 2008 ident: 10.1038/jid.2011.239_bb0215 article-title: Collagen I-mediated up-regulation of N-cadherin requires cooperative signals from integrins and discoidin domain receptor 1 publication-title: J Cell Biol doi: 10.1083/jcb.200708137 – volume: 107 start-page: 1049 year: 2001 ident: 10.1038/jid.2011.239_bb0030 article-title: SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury publication-title: J Clin Invest doi: 10.1172/JCI12939 – volume: 13 start-page: 2129 year: 2003 ident: 10.1038/jid.2011.239_bb0235 article-title: PANTHER: a library of protein families and subfamilies indexed by function publication-title: Genome Res doi: 10.1101/gr.772403 – volume: 139 start-page: 891 year: 2009 ident: 10.1038/jid.2011.239_bb0120 article-title: Matrix crosslinking forces tumor progression by enhancing integrin signaling publication-title: Cell doi: 10.1016/j.cell.2009.10.027 – volume: 54 start-page: 2626 year: 2006 ident: 10.1038/jid.2011.239_bb0280 article-title: Attenuation of collagen production with small interfering RNA of SPARC in cultured fibroblasts from the skin of patients with scleroderma publication-title: Arthritis Rheum doi: 10.1002/art.21973 – volume: 28 start-page: 214 year: 2010 ident: 10.1038/jid.2011.239_bb0140 article-title: Lost in migration publication-title: Nat Biotechnol doi: 10.1038/nbt0310-214 – volume: 108 start-page: 210 year: 1997 ident: 10.1038/jid.2011.239_bb0105 article-title: The expression of the secreted protein acidic and rich in cysteine (SPARC) is associated with the neoplastic progression of human melanoma publication-title: J Invest Dermatol doi: 10.1111/1523-1747.ep12334263 – volume: 264 start-page: 100 year: 1999 ident: 10.1038/jid.2011.239_bb0135 article-title: Exocytosis of active cathepsin B enzyme activity at pH 7.0, inhibition and molecular mass publication-title: Eur J Biochem doi: 10.1046/j.1432-1327.1999.00582.x – volume: 7 start-page: R100 year: 2006 ident: 10.1038/jid.2011.239_bb0045 article-title: CellProfiler: image analysis software for identifying and quantifying cell phenotypes publication-title: Genome Biol doi: 10.1186/gb-2006-7-10-r100 – volume: 139 start-page: 871 year: 2009 ident: 10.1038/jid.2011.239_bb0230 article-title: Epithelial-mesenchymal transitions in development and disease publication-title: Cell doi: 10.1016/j.cell.2009.11.007 – volume: 30 start-page: 339 year: 1999 ident: 10.1038/jid.2011.239_bb0145 article-title: Osteonectin expression correlates with clinical outcome in thin cutaneous malignant melanomas publication-title: Hum Pathol doi: 10.1016/S0046-8177(99)90014-X – volume: 19 start-page: 816 year: 2001 ident: 10.1038/jid.2011.239_bb0040 article-title: SPARC, a matricellular protein: at the crossroads of cell-matrix communication publication-title: Matrix Biol doi: 10.1016/S0945-053X(00)00133-5 – volume: 26 start-page: 4084 year: 2007 ident: 10.1038/jid.2011.239_bb0210 article-title: Targeting SPARC expression decreases glioma cellular survival and invasion associated with reduced activities of FAK and ILK kinases publication-title: Oncogene doi: 10.1038/sj.onc.1210181 – volume: 62 start-page: 58 year: 2002 ident: 10.1038/jid.2011.239_bb0100 article-title: Inhibition of transforming growth factor (TGF)-beta 1-induced extracellular matrix with a novel inhibitor of the TGF-beta Type I receptor kinase activity: SB-431542 publication-title: Mol Pharmacol doi: 10.1124/mol.62.1.58 – volume: 67 start-page: 3450 year: 2007 ident: 10.1038/jid.2011.239_bb0010 article-title: A high-throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasis publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-06-3481 – volume: 274 start-page: 32145 year: 1999 ident: 10.1038/jid.2011.239_bb0060 article-title: SPARC regulates the expression of collagen type I and transforming growth factor-beta1 in mesangial cells publication-title: J Biol Chem doi: 10.1074/jbc.274.45.32145 – volume: 1226 start-page: 117 year: 1994 ident: 10.1038/jid.2011.239_bb0085 article-title: Latency of cathepsin B secreted by human colon carcinoma cells is not linked to secretion of cystatin C and is relieved by neutrophil elastase publication-title: Biochim Biophys Acta doi: 10.1016/0925-4439(94)90018-3 – volume: 3 start-page: 171 year: 1997 ident: 10.1038/jid.2011.239_bb0110 article-title: Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells publication-title: Nat Med doi: 10.1038/nm0297-171 – volume: 12 start-page: 941 year: 2010 ident: 10.1038/jid.2011.239_bb0245 article-title: PTEN augments SPARC suppression of proliferation and inhibits SPARC-induced migration by suppressing SHC-RAF-ERK and AKT signaling publication-title: Neuro Oncol doi: 10.1093/neuonc/noq048 – volume: 26 start-page: 7859 year: 2007 ident: 10.1038/jid.2011.239_bb0130 article-title: Molecular signatures of metaplastic carcinoma of the breast by large-scale transcriptional profiling: identification of genes potentially related to epithelial-mesenchymal transition publication-title: Oncogene doi: 10.1038/sj.onc.1210593 – volume: 34 start-page: 4791 year: 1995 ident: 10.1038/jid.2011.239_bb0255 article-title: Crystal structure of cathepsin B inhibited with CA030 at 2.0-A resolution: A basis for the design of specific epoxysuccinyl inhibitors publication-title: Biochemistry doi: 10.1021/bi00014a037 – volume: 388 start-page: 639 year: 2007 ident: 10.1038/jid.2011.239_bb0180 article-title: Increased carcinogenic potential of myeloid tumor cells induced by aberrant TGF-beta1-signaling and upregulation of cathepsin B publication-title: Biol Chem doi: 10.1515/BC.2007.072 – volume: 6 start-page: 764 year: 2006 ident: 10.1038/jid.2011.239_bb0150 article-title: Cysteine cathepsins: multifunctional enzymes in cancer publication-title: Nat Rev Cancer doi: 10.1038/nrc1949 – volume: 27 start-page: 691 year: 2008 ident: 10.1038/jid.2011.239_bb0165 article-title: The role of the matricellular protein SPARC in the dynamic interaction between the tumor and the host publication-title: Cancer Metastasis Rev doi: 10.1007/s10555-008-9146-7 – volume: 57 start-page: 117 year: 2000 ident: 10.1038/jid.2011.239_bb0025 article-title: Induction of TGF-beta1 by the matricellular protein SPARC in a rat model of glomerulonephritis publication-title: Kidney Int doi: 10.1046/j.1523-1755.2000.00811.x – volume: 24 start-page: 219 year: 2011 ident: 10.1038/jid.2011.239_bb0055 article-title: The p53/p21Cip1/ Waf1 pathway mediates the effects of SPARC on melanoma cell cycle progression publication-title: Pigment Cell Melanoma Res doi: 10.1111/j.1755-148X.2010.00790.x – volume: 277 start-page: 32220 year: 2002 ident: 10.1038/jid.2011.239_bb0095 article-title: Interaction of human breast fibroblasts with collagen I increases secretion of procathepsin B publication-title: J Biol Chem doi: 10.1074/jbc.M204708200 – volume: 26 start-page: 2735 year: 2008 ident: 10.1038/jid.2011.239_bb0160 article-title: IFATS collection: combinatorial peptides identify alpha5beta1 integrin as a receptor for the matricellular protein SPARC on adipose stromal cells publication-title: Stem Cells doi: 10.1634/stemcells.2008-0212 – volume: 14 start-page: 3977 year: 2003 ident: 10.1038/jid.2011.239_bb0200 article-title: SPARC inhibits epithelial cell proliferation in part through stimulation of the transforming growth factor-beta-signaling system publication-title: Mol Biol Cell doi: 10.1091/mbc.e03-01-0001 – year: 2007 ident: 10.1038/jid.2011.239_bb0275 – volume: 17 start-page: 463 year: 1999 ident: 10.1038/jid.2011.239_bb0080 article-title: Increased SPARC expression promotes U87 glioblastoma invasion in vitro publication-title: Int J Dev Neurosci doi: 10.1016/S0736-5748(99)00009-X – volume: 351 start-page: 998 year: 2004 ident: 10.1038/jid.2011.239_bb0250 article-title: Management of cutaneous melanoma publication-title: N Engl J Med doi: 10.1056/NEJMra041245 – volume: 120 start-page: 949 year: 2003 ident: 10.1038/jid.2011.239_bb0035 article-title: SPARC-null mice display abnormalities in the dermis characterized by decreased collagen fibril diameter and reduced tensile strength publication-title: J Invest Dermatol doi: 10.1046/j.1523-1747.2003.12241.x – volume: 77 start-page: 6765 year: 2005 ident: 10.1038/jid.2011.239_bb0260 article-title: Identifying the SPARC binding sites on collagen I and procollagen I by atomic force microscopy publication-title: Anal Chem doi: 10.1021/ac051349d – volume: 283 start-page: 19551 year: 2008 ident: 10.1038/jid.2011.239_bb0065 article-title: Mapping of SPARC/BM-40/osteonectin-binding sites on fibrillar collagens publication-title: J Biol Chem doi: 10.1074/jbc.M710001200 – volume: 22 start-page: 271 year: 2003 ident: 10.1038/jid.2011.239_bb0190 article-title: Pericellular cathepsin B and malignant progression publication-title: Cancer Metastasis Rev doi: 10.1023/A:1023007717757 |
SSID | ssj0016458 |
Score | 2.2960432 |
Snippet | In melanoma, the extracellular protein SPARC (secreted protein acidic and rich in cysteine) is related to tumor progression. Some of the evidence that links... |
SourceID | proquest pubmed pascalfrancis crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 2438 |
SubjectTerms | Biological and medical sciences Cadherins - metabolism Cathepsin B - metabolism Cell Line, Tumor Collagen Type I - metabolism Cytokines - metabolism Dermatology Down-Regulation Epithelial-Mesenchymal Transition Gene Expression Profiling Humans Integrin alpha2beta1 - metabolism Medical sciences Melanoma - metabolism Melanoma - pathology Neoplasm Invasiveness Neoplasm Proteins - metabolism Osteonectin - metabolism Skin Neoplasms - metabolism Skin Neoplasms - pathology Transforming Growth Factor beta1 - metabolism Tumors of the skin and soft tissue. Premalignant lesions |
Title | SPARC Promotes Cathepsin B-Mediated Melanoma Invasiveness through a Collagen I/α2β1 Integrin Axis |
URI | https://dx.doi.org/10.1038/jid.2011.239 https://www.ncbi.nlm.nih.gov/pubmed/21850018 https://www.proquest.com/docview/903657638 |
Volume | 131 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9owFLZoK02Tpmn3sQvyw3hCKcRxSHgEyla6papYK_EW2Y4zZYKAuEzT_tKeth_S37TjOE7CBFK3l4CSOIScL8ffOT4XhN75kgpQjjZov8i3KBGxxT0V404odxlTHF_lOweX3fMbejF1p7Xaz0rU0nbDT8WPvXkl_yNV2AdyVVmy_yDZ4qKwA76DfGELEobtnWT8-ao_GapYf3jecq2z-ZZg_LcGVpC14AA2GcgZSxdzpipqsLXRbaY9D8s8B6BT0tYY7qM5HDUHNsk-iJ25C7-slEfke7I-QGOTslDHN5WDpSjwjqv-Q7JabHTQQMD0wvwZa01Oq57sbK9t3NlB1hixCP34pI4OnKU-eLEFjdQvRg_ZnMUy0Rx4NE9mOq7MODJUJF0RFFImFpBO1l29VM6OXUUhqepaquvC5PM28BRv75ygK8B_TSJdsJXo4km7pbf_mhKLQMVsid7xQxgdqtEhjD5CJwRsEtUu42z8sViy6lLXN6Xp1b_IsyxgdLv624f4z4MlW8NbGet2KoftnYz3XD9CD3NJ475G32NUk-kTdC_IQzKeIpGBEBsQ4gKEuAQhNiDEVRDiHISYYQNCPG7f_iK3v21soIcV9J6hm_ej6-G5lXfusASQnY0FRiuNhR1LGROH857H3B4TfiwcxgX1maCURoRR6VDudEQXOCnMyq7f8aNO7Max8xwdp4tUvkS4y1whXNqzo8imXOWJcy48zqQTEbBmSB21zPMMRV7WXnVXmYX7ZFdHzeLspS7ncuC8thFNmFNRTTFDQNWBEY0dCRaXJ9RXRhLcKDYiDUGFq3U5lsrFdh32gEWC2e_4dfRCi7ocDHRa9c18dcf7fo3ul6_WG3S8WW3lW2DNG95AR97Ua6CTwejyatLIsPsH8h3Bog |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=SPARC+Promotes+Cathepsin+B-Mediated+Melanoma+Invasiveness+through+a+Collagen+I%2F%CE%B12%CE%B21+Integrin+Axis&rft.jtitle=Journal+of+investigative+dermatology&rft.au=Girotti%2C+Mar%C3%ADa+R.&rft.au=Fern%C3%A1ndez%2C+Marisol&rft.au=L%C3%B3pez%2C+Juan+A.&rft.au=Camafeita%2C+Emilio&rft.date=2011-12-01&rft.issn=0022-202X&rft.volume=131&rft.issue=12&rft.spage=2438&rft.epage=2447&rft_id=info:doi/10.1038%2Fjid.2011.239&rft.externalDBID=n%2Fa&rft.externalDocID=10_1038_jid_2011_239 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-202X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-202X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-202X&client=summon |